Program Schedule

Approach to Clinical Infections

Friday, October 10, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

DRIP – Drug Resistance In Pneumonia: Derivation and Prospective Multi-center Validation of a Scoring Model to Predict Drug-Resistant Pathogens
Brandon Webb, MD ; Edward Stenehjem, MD MSc ; Kristin Dascomb, MD, PhD ; Holenarasipur R. Vikram, MD, FACP, FIDSA ; Neera Agrwal, MD ; Kenneth K. Sakata, MD ; Kathryn Williams, MD ; Bruno Bockorny, MD ; Kavitha Bagavathy, MD ; Shireen Mirza, MD ; Mark Metersky, MD ; Nathan Dean, MD
  • DRIP IDSA poster.pdf (1.2 MB)
  • 670
    Trends and Microbiology of Infective Endocarditis in Children during 2000-2010 in United States
    Shipra Gupta, MD ; Ankit Sakhuja, MBBS FACP FASN ; Eric McGrath, MD ; Basim Asmar, MD
  • endocarditisposter1.pdf (161.6 kB)
  • 671
    Greater Hospital-Complexity and Case-Volume are Associated with Lower Mortality among Patients with Staphylococcus aureus Bacteremia
    Michihiko Goto, MD ; Marin Schweizer, PhD ; Kelly Richardson, PhD ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Mary Vaughand-Sarrazin, PhD ; Michael Ohl, MD, MSPH
  • IDWeek 2014 poster final.pdf (532.0 kB)
  • 672
    Staphylococcus aureus Bacteremia in Hospitalized Children
    Sarah B. Klieger, MPH ; Neika Vendetti, MPH ; Brian T. Fisher, DO, MSCE ; Jeffrey S. Gerber, MD, PhD
    Comparative Effectiveness of Vancomycin versus Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
    Pamela Moise, PharmD ; Darren Culshaw, PharmD ; Annie Wong-Beringer, PharmD ; Joyce Bensman, PharmD ; Kenneth Lamp, PharmD ; Winter J. Smith, PharmD ; Karri Bauer, PharmD ; Debra Goff, PharmD ; Robert Adamson, PharmD ; Kimberly Leuthner, PharmD ; Michael Virata, MD ; James a. Mckinnell, MD ; Saira B. Chaudhry, PharmD, MPH ; Romic Eskandarian, PharmD ; Thomas Lodise, PharmD ; Katherine Reyes, MD ; Marcus Zervos, MD
    Comparison of the Microbiology and Antibiotic Treatment between Diabetic and Non-Diabetic Patients Hospitalized with Acute Bacterial Skin and Skin Structure Infection
    Timothy Jenkins, MD ; Bryan Knepper, MPH, MSc ; S. Jason Moore, PhD, PA ; Bruce Mccollister, MD ; Carla Saveli, MD ; Sean Pawlowski, MD ; Daniel Perlman, MD ; William Burman, MD
    Distinct microbial species in acute and chronic wounds in community-recruited injection drug users: Antimicrobial sensitivity more common than not
    Maria Elisa Smith, BS BA ; Natanya Robinowitz, MSPH ; C. Patrick Chaulk, MD, MPH ; Kristine Johnson, MD, MSc
    Ceftaroline Versus Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients
    Hao Nguyen, MD ; Kaushal Shah, MD ; Manjit Dhillon ; Michael Gooch, Pharm D ; Paul Cook, MD
  • Ceftaroline IDSA- Final.pdf (244.9 kB)
  • 679
    Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients
    Keith Kaye, MD, MPH, FIDSA, FSHEA ; David Guervil, PharmD ; Ananthakrishnan Ramani, MD ; Alena Jandourek, MD ; H. David Friedland, MD
    Predictors of Recurrent Staphylococcus aureus Skin Infection After Treatment: Host, Behavioral, and Pathogen Level Factors
    Loren Miller, MD, MPH ; Samantha J. Eells, MPH ; Michael Z David, MD PhD ; Nancy Ortiz ; Susan Boyle-Vavra, PhD ; Robert S Daum, MD
    Microscopically Diagnosed Necrotizing Fasciitis: A Series of 29 Patients ---Can We Depend on the Macroscopic Findings ? ---
    Kiyoharu Muranaka, MD ; Naoto Hosokawa, MD, PhD ; Ryota Hase, MD ; Yoshifumi Uwamino, MD ; Takahiro Mikawa, MD ; Daisuke Suzuki, MD ; Shunsuke Uno, MD ; Kazuyasu Miyoshi, MD ; Koji Fujita, MD ; Hiroyuki Suzuki, MD ; Yoshihito Otsuka, PhD
  • ID WEEK 2014 NF 2.pdf (349.7 kB)
  • 682
    Microbiology and Antibiotic Treatment among Injection Drug Users and Non-Injection Drug Users Hospitalized with Acute Bacterial Skin and Skin Structure Infection
    Timothy Jenkins, MD ; Bryan Knepper, MPH, MSc ; S. Jason Moore, PhD, PA ; Bruce Mccollister, MD ; Carla Saveli, MD ; Sean Pawlowski, MD ; Daniel Perlman, MD ; William Burman, MD
    A Festering Affliction: Etiology and Clinical Manifestations of Thorn-Associated Infections
    Sierra Simmons, MD ; Shimon Kusne, MD ; Holenarasipur R. Vikram, MD, FACP, FIDSA ; Qing Wu, ScD ; Ann Marie Roy-Hughes, RN ; Janis Blair, MD
    Time to Onset and Duration of Adverse Events in Patients with Acute Bacterial Skin and Skin Structure Infections Treated with Oritavancin – The SOLO Studies
    Ralph Corey, MD ; W O'riordan, MD ; Norman Huang, MD ; Hai Jiang ; Samantha Good ; Philip Giordano, MD ; Matthew Wikler, MD
    A Fishmonger's Tale
    Lysenia Mojica, MD ; Lily Jones, DO ; Abraham Yacoub, MD ; Tyler Janz, BS ; John Greene, M.D., F.A.C.P.
    The Effect of Preoperative Vancomycin on Bacteria Isolation from Operative Cultures
    Heather Young, MD ; Bryan Knepper, MPH, MSc ; Whitney Hernandez, NP ; Susan Heard, BS ; Connie Price, MD
  • Preop-Vanco-ver2.pdf (492.5 kB)
  • 689
    Enhanced Detection of Staphylococcus aureus Colonization in Patients Undergoing Total Joint Arthroplasty
    Angela Hewlett, MD, MS ; Tyler White, BS ; Andrew Taiber, MD ; Dana Schwarz, RN MS ; Dillon Ellis, BS ; Paul Fey, PhD ; Elizabeth Lyden, MS ; Kevin Garvin, MD ; Beau Konigsberg, MD ; Curtis Hartman, MD
    16s rRNA Gene PCR: An Unreliable Tool for the Diagnosis of Prosthetic Joint Infections (PJI)
    Michael a. Lane, MD, MSc ; Carey-Ann Burnham, PhD ; Alice P. Gu, MPH ; Neeraja Ganeshraj, MPH ; Qian Liu, MPH ; Shadi Parsaei, DO ; David K. Warren, MD, MPH, FIDSA, FSHEA
    Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
    Shadi Parsaei, DO ; Neeraja Ganeshraj, MPH ; Alice P. Gu, MPH ; Qian Liu, MPH ; Carey-Ann D. Burnham, PhD ; David K. Warren, MD, MPH, FIDSA, FSHEA ; Michael a. Lane, MD, MSc
    Prognostic Value of Inflammatory Markers during Treatment of Prosthetic Joint Infections
    Upasna Manchanda, MD ; Wissam El Atrouni, MD ; Michael Brimacombe, PhD ; Albert Eid, MD
  • PJIposter.pdf (112.6 kB)
  • 693
    Comparison of the 2011 Musculoskeletal Infection Society (MSIS), the 2013 International Consensus Meeting (ICM) and the Infectious Diseases Society of America (IDSA) Diagnostic Criteria for Prosthetic Joint Infection (PJI)
    Dante Melendez, MD ; Douglas Osmon, MD ; Kerryl E. Greenwood Quaintance ; Arlen D. Hanssen, MD ; Robin Patel, MD, FIDSA, FRCP(C), D(ABMM), FACP, F(AAM)
    Bone and joint infection due to bacteria producing Extended Broad Spectrum Beta lactamase
    Claire Rouzaud ; Guillaume Mellon ; Thomas Bauer ; Beate Heym ; Anne-Laure Roux ; Thierry Judet ; Christian Perronne ; Aurelien Dinh, MD
    Bone and Joint  Infections in Children in the Era of Community- Acquired Meticillin- Resistant S. aureus
    Maria Teresa Rosanova, PhD ; Sandra Gimenez ; Rosa Bologna ; Ana Buchovsky ; Griselda Berberian, MD ; Natalia Escudé ; Guadalupe Perez ; Claudia Sarkis ; Jose L Pinheiro ; Roberto Lede
  • Slide1.PNG (476.6 kB)
  • 696
    Relative Contribution of Blood and Bone Cultures in the Microbiologic Diagnosis of Staphylococcus aureus Osteomyelitis in Children
    Jonathon Mcneil, MD ; Andrea Forbes, RN ; Edward O. Mason Jr., PhD ; Kristina G. Hulten, PhD ; Sheldon L. Kaplan, MD, FIDSA ; Jesus G. Vallejo, MD, FIDSA
  • Osteo poster.pdf (319.7 kB)
  • 697
    Treatment and Outcome of Culture-negative Osteomyelitis in Children
    Felice C. Adler-Shohet, MD ; Antonio Arrieta, MD ; Kevin S. Kleis, DO ; Elizabeth a. Trent, MD ; Andrew Powers Davis ; Jasjit Singh, MD ; John a. Schlecter, DO ; Nathan M. Moroski ; Jennifer Le, PharmD, BCPS-ID, FCCP
    Optimal Duration of Antibiotic Therapy in Patients with Hematogenous Vertebral Osteomyelitis Who Undergo and Do Not Undergo Surgical Debridement
    Ki-Ho Park, MD ; Oh-Hyun Cho, MD ; In-Gyu Bae, MD ; Yu-Mi Lee, MD ; Chisook Moon, MD ; Seong Yeon Park, MD ; Sung-Han Kim, MD ; Sang-Oh Lee, MD ; Sang-Ho Choi, MD ; Jun Hee Woo, MD ; Yang Soo Kim, MD ; Mi Suk Lee, MD
    Long Term Outcome of Pyogenic Vertebral Osteomyelitis:  A Cohort Study of 260 Patients
    Arjun Gupta, MBBS ; Todd Kowalski, MD ; Douglas Osmon, MD ; Mark Enzler, MD ; James Steckelberg, MD ; Paul Huddleston, MD ; Ahmad Nassr, MD ; Jayawant Mandrekar, PhD ; Elie F. Berbari, MD
  • Poster PVO IDSA.pdf (215.6 kB)
  • 700
    A cohort of pneumococcal bone and joint infections in adult patients
    Rafael Mahieu ; Claire Rouzaud ; Tristan Ferry ; Valérie Zeller ; Ilker Uckay ; Laurence Legout, MD ; Eric Senneville, MD, PhD ; Louis Bernard, MD ; PhD ; Aurelien Dinh, MD
    Acute Bacterial Arthritis: How Long Should You Wait for Culture Results?
    Percy Balderia, MD ; Robert Fischer, MD ; Sherry Pomerantz, PhD
    A Bone of Contention for Culture Selection
    Sameer Avasarala, MD ; Anee Khan, MSIII ; Daniela Moreno, B.S. ; Marcus J. Zervos, MD ; Katherine C. Reyes, MD
  • ID Week Poster FINAL.pdf (471.1 kB)
  • 705
    Correlation of Radiologic Tests in the Diagnosis of Brucellosis with Osteoarticular Involvement
    Behice Kurtaran ; Ozay Akyildiz ; Aslihan Candevir Ulu ; Ayse Seza Inal ; Suheyla Komur ; Hasan Salih Zeki Aksu ; Yesim Tasova
  • IDSA POSTER 2014.pdf (255.0 kB)
  • 707
    Rapid Identification of Pathogens Causing Septic Arthritis using FilmArray®
    Susan K. Sanderson, DNP ; Krow Ampofo, MD ; Jarrett Killpack, BSc ; Caroline Heyrend, PharmD ; Pricilla Cowan ; Chris Stockmann, MSc ; Judy Daly, PhD ; Anne J. Blaschke, MD, PhD
  • IDSA 2014 Poster (SA) Final.pdf (876.5 kB)
  • 708
    Risk Factors for Infections after Open Fractures - Opportunities for Improving Prophylactic Antimicrobial Therapy
    Kamla Sanasi- Bhola, MD ; Sharon Weissman, MD ; Joseph Horvath, MD ; Rebecca Berdel, MD ; Stephan Albrecht, BS ; Melanie Whitmire, MA ; David Parker, PhD ; Helmut Albrecht, MD
  • Osteo Final Poster.jpg (1009.4 kB)
  • 709
    Clinical Epidemiology of Obligate Anaerobic Infections in Military Trauma Patients from Iraq and Afghanistan
    Brian White, DO ; Amy Weintrob, MD ; Katrin Mende, PhD ; Miriam Beckius, MPH ; Wendy Zera, BS ; Dan Lu, MS ; William P. Bradley, MS ; David Tribble, MD, DrPH ; Clinton K. Murray, MD ; Elizabeth Rini, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek